AMERICAN GENE TECHNOLOGIES INTERNATIONAL INC.

Amendment

CIK: 0001586824·Biotechnology·DELAWARE·Filed: Dec 22, 2025

Total Offering

$10,000,000

Amount Sold

$310,000

Investors

4

First Sale

Nov 3, 2025

Offering Details

Type: Equity, Other: SAFE (Simple Agreement for Future Equity)
Exemptions: Rule 506(b)

Related Persons

Name	Role
Jeffrey Adam Galvin	Executive Officer, Director
William Drew Palin	Executive Officer, Director
Barry Haden Wells	Director

Company

American Gene Technologies International Inc.

108 MONROE STREET, SUITE 202

ROCKVILLE, MD, 20850

301-337-2100

SEC Filing

0001586824-25-000005

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.